FDA Rejects Two Proposed Cancer Drugs Developed in China
The Food and Drug Administration rejected two proposed new cancer drugs that were developed in China, underscoring a tougher U.S. regulatory stance toward such drugs.Hong Kong-based…
Browsing Tag
1801.HK
FDA Raises Concerns About China-Developed Drugs
U.S. regulators are poised to tap the brakes on approving dozens of cancer drugs and other new medicines developed in China.The regulators have expressed concerns about the quality of…